Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

76740 Press Releases
DateTitleCompany
07 Jan 13 Research and Markets: Merck KGaA and Oncothyreon's Stimuvax - A Therapeutic Vaccine for Lung Cancer Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: Targacept's TC-5214: Neuronal nicotine receptors - a target for depression therapy Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: NuPathe's Zelrix: The First Transdermal Sumatriptan Patch Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: AVEO Pharmaceuticals' and Astellas Pharma's Tivozanib - Can this angiogenesis inhibitor distinguish itself from the field? Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: Pfizer's tofacitinib - JAK inhibition -a new rheumatoid arthritis therapy paradigm Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: Targacept's TC-5619 - The prospects for this fully-owned alpha-7 neuronal nicotinic receptor agonist Research and Markets,
Published by
Business Wire
07 Jan 13 iCAD Receives FDA Approval for Digital CAD with Philips Digital Mammography System iCAD Inc.,
Published by
Business Wire
07 Jan 13 Dendreon Announces Preliminary Fourth Quarter 2012 Revenues Dendreon Corporation,
Published by
Business Wire
07 Jan 13 America Stem Cell, Inc. Awarded a Phase I SBIR to Explore the Therapeutic Potential of Its Platform Technology (ASC-101) with Neural Stem Cells in Multiple Sclerosis Model America Stem Cell Inc.,
Published by
Business Wire
07 Jan 13 Natus Medical Announces 2013 Annual and First Quarter Financial Guidance Natus Medical Incorporated,
Published by
Business Wire
07 Jan 13 Rolland Carlson, Ph.D. named CEO of Asuragen Asuragen Inc.,
Published by
Business Wire
07 Jan 13 The Colorado BioScience Association Launches Its Colorado BioScience Institute to Support Much Needed Educational & Workforce Programs for the State's Bioscience Industry Colorado BioScience Association,
Published by
Business Wire
07 Jan 13 Baxter to Initiate Late-Stage Clinical Trial of BAX 855 for the Treatment of Hemophilia A Baxter International Inc.,
Published by
Business Wire
07 Jan 13 ARIAD AND THE U.K. NATIONAL CANCER RESEARCH INSTITUTE TO COLLABORATE ON SPIRIT 3 CLINICAL STUDY ARIAD Pharmaceuticals, Inc,
Published by
Biosector 2
07 Jan 13 Vaccinex, Inc. Announces Initiation of a Phase 1 Clinical Trial of VX15/2503 Antibody in Multiple Sclerosis Patients VACCINEX INC.,
Published by
PR Newswire
07 Jan 13 Innovative Approach to Laser Skin Care Keeps MAS Patients Coming Back for More Manhattan Aesthetic Surgery,
Published by
Business Wire
07 Jan 13 BrainStorm's Clinical Trial is Fast-Tracked to Phase IIa, Representing a Major Milestone for the Company BrainStorm Cell Therapeutics Inc.,
Published by
Business Wire
07 Jan 13 Research and Markets: YM Biosciences's JAK-2 Inhibitor for Myelofibrosis - Could this be the best in class? Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: OTC Pharmaceuticals and Self-medication in Seven Emerging Markets Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: Columbus, OH Healthcare Market Overview Research and Markets,
Published by
Business Wire
07 Jan 13 Cancer Research Breakthrough: The National Foundation for Cancer Research (NFCR) Cites Manhattan Scientifics’ Early Cancer Detection Technology as “Research Breakthrough” for 2012 Manhattan Scientifics Inc.,
Published by
Business Wire
07 Jan 13 Research and Markets: Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022 Research and Markets,
Published by
Business Wire
07 Jan 13 CytoDyn to Attend 31st Annual J.P. Morgan Healthcare Conference CytoDyn Inc.,
Published by
Business Wire
07 Jan 13 Research and Markets: Hemorrhagic Shock Global Clinical Trials Review, H2, 2012 Research and Markets,
Published by
Business Wire
07 Jan 13 Research and Markets: Rigel/AstraZeneca's R788 (fostamatinib) - an oral Syk inhibitor for rheumatoid arthritis Research and Markets,
Published by
Business Wire
07 Jan 13 Infinity Provides Key 2013 Goals and Financial Guidance Infinity Pharmaceuticals Inc.,
Published by
Business Wire
07 Jan 13 BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013 BioLineRx,
Published by
Business Wire
07 Jan 13 Advanced Cell Technology to Present at Biotech Showcase™ 2013 Advanced Cell Technology Inc.,
Published by
Business Wire
07 Jan 13 Advaxis to Present at the 6th Annual OneMedForum Advaxis Inc.,
Published by
Business Wire
07 Jan 13 Cubist Announces Full-Year 2012 Revenues and Provides Business Update Cubist Pharmaceuticals Inc,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.